Paddington Life Sciences Partners will be a key driver of the Paddington Life Sciences development.

Paddington Life Sciences Partners is a partnership group - made up of NHS, industry, community and academic organisations - with a shared commitment to generating healthcare innovation, alongside health, economic and social value, through a new life sciences cluster centred around St Mary’s Hospital in Paddington.

Members of Paddington Life Sciences Partners have committed to, and are investing in, developing a life sciences cluster in Paddington that achieves major health, social and economic value. There are also associate members that have a strategic advisory role and may also support specific projects.

Paddington Life Sciences Partners are: British Land, Brockton Everlast, Derwent London, Imperial College Healthcare NHS Trust, Imperial College London, IQVIA, Microsoft, Optum, Oracle Health, Takeda, The Paddington Partnership, Vertex and Vodafone. The Associate Partners are: Imperial College Health Partners and Imperial Health Charity.


Paddington Life Sciences Partners have agreed to work together to improve health and reduce inequalities through four key areas of focus:

Paddington Life Sciences Partners logo board

Talk to us now and get involved

Find out more about our vision for Paddington Life Sciences